Administration of EP2-receptor agonist did not affect proinflammatory cytokine production from Th17 cells of healthy individuals but increased IFN-γ and cerebrospinal fluid (CSF) 2 production from Th17 cells isolated from MS patients (Kofler et al., 2014). The gene discussed is IFNG; the disease is myeloid sarcoma.